GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (FRA:7JK) » Definitions » 5-Year Yield-on-Cost %

EQL Pharma AB (FRA:7JK) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is EQL Pharma AB 5-Year Yield-on-Cost %?

EQL Pharma AB's yield on cost for the quarter that ended in Mar. 2024 was 0.00.


The historical rank and industry rank for EQL Pharma AB's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:7JK's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.29
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of EQL Pharma AB's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EQL Pharma AB's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's 5-Year Yield-on-Cost % falls into.



EQL Pharma AB 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of EQL Pharma AB is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

EQL Pharma AB  (FRA:7JK) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


EQL Pharma AB 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


EQL Pharma AB (FRA:7JK) Business Description

Traded in Other Exchanges
Address
Stortorget 1, 3rd Floor, Lund, SWE, 222 23
EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (FRA:7JK) Headlines

No Headlines